Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2021-06-22 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Transaction in Own Shares Classification · 1% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 14 au 18 Juin 2021" (Declaration of transactions on own shares carried out from June 14 to 18, 2021). The content is a table detailing the volume, weighted average price, and date of transactions involving the company's own shares (share repurchase/issuance). This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is a formal declaration of these specific transactions.
2021-06-22 French
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document explicitly details a 'Disclosure transaction in own shares' occurring between specific dates (14/06/2021 and 18/06/2021). It provides aggregated data on the volume and weighted average price of shares acquired by the issuer (IPSEN). This content directly matches the definition for 'Transaction in Own Shares' (share repurchase/issuance), which corresponds to the filing code POS.
2021-06-22 English
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document explicitly details a 'Disclosure transaction in own shares' occurring between specific dates (07/06/2021 and 11/06/2021). It provides a table summarizing the daily volume and weighted average price of shares acquired. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. The corresponding filing type code is POS (Transaction in Own Shares). The document length is short (2402 chars), but it contains the full data, not just an announcement of data, thus it is not an RPA.
2021-06-15 English
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Transaction in Own Shares Classification · 1% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 7 au 11 Juin 2021" (Declaration of transactions on own shares carried out from June 7 to 11, 2021). The content is a detailed table showing the volume, price, and date of share transactions conducted by the issuer (IPSEN) on its own stock. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing type code is POS (Transaction in Own Shares). The document is short and contains the actual transaction data, not just an announcement of a report, so RPA/RNS is not the primary classification.
2021-06-15 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces findings from a new analysis being presented at the ISPRM 2021 Congress. It details data analysis regarding spasticity treatment patterns in the U.S. using commercial claims databases (MarketScan and IQVIA). This content—announcing research findings, often related to clinical data or market insights, released via a press release format—is characteristic of an Earnings Release (ER) or a general announcement. Since it is not a full financial report (10-K, IR), a transcript (CT), or a formal regulatory filing announcing a report (RPA), and it focuses on business/research updates, it aligns best with the 'Earnings Release' category, which often includes key operational or research highlights outside of mandatory financial statements. Given the context of Ipsen presenting data at a medical congress, it functions as a key business update announcement.
2021-06-11 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the results of a new analysis by Ipsen regarding spasticity treatment, which will be presented at the ISPRM 2021 virtual congress. It details data findings from US commercial claims databases (MarketScan and IQVIA) concerning the low utilization rate of Botulinum Toxin Type A (BoNT-A) for spasticity. This type of announcement, focusing on new data findings, scientific presentations, and general corporate updates released to the public via press release, most closely aligns with an Earnings Release (ER) if it were quarterly results, or more generally, a Regulatory Filing (RNS) if it doesn't fit a specific financial report category. Since this is a scientific/data announcement rather than a formal financial report (like 10-K or IR) or a management discussion (MDA), and it is a general public announcement, the most appropriate category is the general Regulatory Filings/Announcements category (RNS). It is not a Call Transcript (CT), Investor Presentation (IP), or a formal Earnings Release (ER) which typically focuses on P&L/Balance Sheet figures for a reporting period. Given the nature of a press release disseminating scientific/market data, RNS is the best fit as a broad regulatory/public disclosure category.
2021-06-11 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.